Shell Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-14,807
Closed -$137K 1273
2023
Q4
$137K Sell
14,807
-4,462
-23% -$36.5K 0.01% 978
2023
Q3
$195K Buy
+19,269
New +$230K 0.01% 913

Other funds holding HCAT

Shell Asset Management's HCAT Position: Q1 2024 in Review

Shell Asset Management sold out of Health Catalyst (HCAT) in Q1 2024, closing a stake of 14,807 shares — an estimated $137K sold.

Shell Asset Management first reported a position in HCAT in Q3 2023 and held it in 2 quarters. The position peaked at $195K in Q3 2023. 174 funds tracked by Wall St. Rank hold HCAT as of Q1 2024.

  • Shell Asset Management reported no remaining Health Catalyst position as of Q1 2024 after selling out during the quarter.
  • Shell Asset Management sold 14,807 Health Catalyst shares in Q1 2024, an estimated $137K.
  • Shell Asset Management first reported a position in Health Catalyst in Q3 2023 and held it in 2 quarters.
  • Shell Asset Management's Health Catalyst position peaked at $195K in Q3 2023.
  • 174 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2024.

Based on Shell Asset Management's 13F filing for Q1 2024, filed 14 May 2024.